• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$33.56 $0.21 (0.63%)

REAL-TIME: Last trade at

Charles River Laboratories

NYSE:CRL

Charles River Labs removed from Catalyst Driven Idea List at Sterne Agee

Buy One, Get One Free At Charles River Laboratories

Buy One, Get One Free at Charles River Laboratories

Buy One, Get One Free At Charles River Laboratories

Charles River Laboratories International's CEO Discusses Q1 2012 Results - Earnings Call Transcript

Charles River Labs reports Q1 EPS 70c, consensus 65c

Charles River Labs affirms FY12 adj EPS view $2.60-$2.70, consensus $2.69

Charles River Laboratories (CRL) Tops Q1 EPS by 5c

Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

The Alzheimer's Drug Discovery Foundation and Charles River Announce Awards for the Cognitive Aging and Alzheimer's Disease Research Program

Charles River Schedules First-Quarter 2012 Earnings Release and Conference Call

Charles River Labs CEO earns first bonus in three years

Technical Tuesday - Charles River Laboratories International (CRL) Bullish Breakout

WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2011 Results, Share Repurchase Program

EMD Millipore Partners With Charles River Laboratories For Improved Viral Clearance Studies

EMD Millipore Partners with Charles River Laboratories for Improved Viral Clearance Studies

Charles River to Present at Upcoming Investor Conferences

6 Stocks With Upgrades: CRL, CCJ, SVM, ACM, TPX, FLIR

Jefferies Lifts Numbers On Charles River Labs (CRL) Following Q4 Results

Charles River Labs price target raised to $42 from $38 at RW Baird

Charles River Laboratories' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Charles River Laboratories (CRL) Is Climbing On Q4 Earnings News

Charles River Labs (CRL) Issues Solid Q4 Results; Reaffirms FY12 Outlook

Charles River Labs reports Q4 RMS segment revenue up 8.3% to $182.4M

Charles River Announces Fourth-Quarter and Full-Year 2011 Results from Continuing Operations

Stocks Rise on Greek Vote

Stocks to Watch: Apple, GE (Update 1)

Earnings Watch For February 13 (CRL, HMA, FIS, GPRO)

Top Earnings Previews For The Week Ahead (CRL, CIM, NAT, RAX, AVP, GT, MET, OMC, ZNGA, A, NVDA, PCG, DVN, DE, NTAP, CMCSA, APA, DTV, WM, JWN, AMAT, DUK, HNZ, CPB)

Charles River to Present at UBS and Leerink Swann Conferences

Jefferies expects Charles River Labs to sell-off post Covance results

10 Top Morningstar M&A Stock Picks

Charles River Schedules Fourth-Quarter and Full-Year 2011 Earnings Release and Conference Call

The Long-Term Play In Lab Work (BBH, CRL, ICLR, PRXL, WX)

CROs Will Return to Relevance in 2012

Charles River Laboratories (Massachusetts) May be Split Up in Sale

Charles River sale? Not so fast, analyst says

Charles River Labs volatility up on wide share price movement

Charles River Labs may be worth mid-$40s in a takeout, says William Blair

Charles River Labs shares surge on takeover rumor

See More Articles...